Document Detail


Identification of universal mRNA markers for noninvasive prenatal screening of trisomies.
MedLine Citation:
PMID:  20661890     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The discovery of placental transcripts in peripheral blood of pregnant women prompted us to investigate which was the most appropriate biological specimen, between plasma and serum, to easily detect them and to exploit hPL (human placental lactogen), betahCG (human chorionic gonadotrophin beta-subunit), LOC90625, and TFPI2 (tissue factor pathway inhibitor 2) levels in order to establish whether an abnormal variation degree of presence of these placental transcripts are likely to be associated to specific fetal trisomies.
METHOD: RNA was extracted from plasma and serum samples of 255 pregnant women bearing euploid fetuses, 17 bearing fetuses affected by trisomy 21 and 10 with fetuses affected by trisomy 18. Placental transcript analysis was performed by real time RT-PCR using relative quantification.
RESULTS: Results obtained from euploid samples showed that fetal transcripts were more abundant in plasma than in serum samples. Euploid samples had a placental transcript abundance distinguishable from those with trisomy 21 but not from those with trisomy 18. In particular, high betahCG abundance and advanced maternal age were significantly associated with trisomy 21 pregnancy.
CONCLUSION: Plasma was the most suitable tool to be employed in the detection and dosage of placental transcripts. betahCG transcript together with maternal age could be a potential marker for noninvasive prenatal screening of fetal trisomy 21.
Authors:
Elena Picchiassi; Giuliana Coata; Michela Centra; Luana Pennacchi; Vittorio Bini; Gian Carlo Di Renzo
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Prenatal diagnosis     Volume:  30     ISSN:  1097-0223     ISO Abbreviation:  Prenat. Diagn.     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-07-27     Completed Date:  2010-11-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8106540     Medline TA:  Prenat Diagn     Country:  England    
Other Details:
Languages:  eng     Pagination:  764-70     Citation Subset:  IM    
Copyright Information:
(c) 2010 John Wiley & Sons, Ltd.
Affiliation:
Department of Obstetrics and Gynecology, Hospital S. Maria della Misericordia, University of Perugia, Perugia, Italy. CMPR-LAB@unipg.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Chorionic Gonadotropin, beta Subunit, Human / blood,  genetics*
Chromosomes, Human, Pair 18*
Down Syndrome / blood,  diagnosis,  genetics*
Female
Genetic Markers
Humans
Lipoproteins / blood,  genetics*
Logistic Models
Placental Lactogen / blood,  genetics*
Pregnancy
Prenatal Diagnosis / methods*
RNA, Messenger / blood*
Reverse Transcriptase Polymerase Chain Reaction
Trisomy / diagnosis,  genetics*
Chemical
Reg. No./Substance:
0/Chorionic Gonadotropin, beta Subunit, Human; 0/Genetic Markers; 0/Lipoproteins; 0/RNA, Messenger; 0/lipoprotein-associated coagulation inhibitor; 9035-54-5/Placental Lactogen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Carrier detection and prenatal diagnosis of congenital adrenal hyperplasia must identify 'apparently...
Next Document:  Women's experience of pre-implantation genetic diagnosis: a qualitative study.